We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-4.45%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.08B
AUM Growth
+$322M
Cap. Flow
+$648M
Cap. Flow %
21%
Top 10 Hldgs %
37.4%
Holding
321
New
89
Increased
78
Reduced
45
Closed
96

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$32M
2
CCCC icon
C4 Therapeutics
CCCC
+$14.5M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$14.1M
4
AMRS
Amyris Inc.
AMRS
+$11M
5
TECH icon
Bio-Techne
TECH
+$10.3M

Top Sells

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$14.1M
2
DXCM icon
DexCom
DXCM
+$14.1M
3
ICUI icon
ICU Medical
ICUI
+$14M
4
LIVN icon
LivaNova
LIVN
+$12.2M
5
OLPX
Olaplex Holdings
OLPX
+$11.6M

Sector Composition

Rank Sector Weight
1 Healthcare 24.06%
2 Materials 0.35%
3 Industrials 0.17%
4 Consumer Discretionary 0.07%
5 Financials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UPC icon
176
Universe Pharmaceuticals Inc
UPC
$3.93M
$1.37M 0.04%
300
-10
-3% -$50.7K
ACET icon
177
Adicet Bio
ACET
$77.3M
$1.33M 0.04%
4,164
-4,387
-51% -$1.01M
BHVN
178
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1.3M 0.04%
10,985
+100
+0.9% +$12.5K
QNCX icon
179
CALL
Quince Therapeutics
QNCX
$31.8M
$1.24M 0.04%
+1,000
New +$1.36M
AGL icon
180
Agilon Health
AGL
$1.45B
$1.14M 0.04%
1,800
-7,448
-81% -$3.84M
CAH icon
181
PUT
Cardinal Health
CAH
$54.5B
$1.13M 0.04%
+20,000
New +$1.07M
NAUT icon
182
Nautilus Biotechnolgy
NAUT
$114M
$1.06M 0.03%
244,698
+100,900
+70% +$414K
OBIO icon
183
Orchestra BioMed
OBIO
$266M
$1.03M 0.03%
104,026
+500
+0.5% +$4.94K
GBT
184
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.02M 0.03%
+29,454
New +$881K
GERN icon
185
CALL
Geron
GERN
$1.01B
$956K 0.03%
+702,600
New +$783K
UBX
186
CALL
DELISTED
Unity Biotechnology
UBX
$878K 0.03%
+78,380
New +$879K
CYCN icon
187
Cyclerion Therapeutics
CYCN
$18.4M
$862K 0.03%
38,825
+240
+0.6% +$5.78K
AGEN
188
CALL
Agenus
AGEN
$311M
$858K 0.03%
+17,771
New +$960K
CRVS icon
189
Corvus Pharmaceuticals
CRVS
$1.27B
$813K 0.03%
495,484
+3,100
+0.6% +$5.67K
GOSS icon
190
Gossamer Bio
GOSS
$86.8M
$763K 0.02%
87,929
+500
+0.6% +$4.82K
HLTH
191
PUT
DELISTED
Cue Health Inc. Common Stock
HLTH
$739K 0.02%
+114,500
New +$1.04M
MDVL
192
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$693K 0.02%
14,282
– –
IRON icon
193
Disc Medicine
IRON
$3.09B
$690K 0.02%
16,537
+103
+0.6% +$5.4K
TNGX icon
194
Tango Therapeutics
TNGX
$4.31B
$627K 0.02%
82,727
+500
+0.6% +$4.33K
RCOR
195
DELISTED
Renovacor, Inc.
RCOR
$616K 0.02%
145,390
-5,115
-3% -$30.6K
TXMD icon
196
TherapeuticsMD
TXMD
$24.1M
$615K 0.02%
+32,382
New +$509K
KALV
197
DELISTED
KalVista Pharmaceuticals
KALV
$610K 0.02%
41,393
+306
+0.7% +$4.4K
QTNT
198
CALL
DELISTED
Quotient Limited Ordinary Shares
QTNT
$600K 0.02%
12,500
-28,723
-70% -$1.72M
ISEE
199
PUT
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$572K 0.02%
34,000
+14,400
+73% +$213K
ABOS icon
200
Acumen Pharmaceuticals
ABOS
$181M
$568K 0.02%
145,195
+19,135
+15% +$104K
6 7
8
9 10

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2022 Portfolio in Review

As of Q1 2022, Pura Vida Investments held 321 positions worth $3.08B, up 12% from $2.76B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Pura Vida Investments deployed $648M of net new capital in Q1 2022, opening 89 new positions and adding to 78 existing holdings. Its largest new stake was Biogen: 147,135 shares worth $31M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 30% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was ICU Medical, an estimated $14M trimmed.

  • Pura Vida Investments's largest Q1 2022 buy was Biogen: 147,135 shares worth $31M.
  • Pura Vida Investments added most to C4 Therapeutics in Q1 2022, an estimated $14.5M increase.
  • Pura Vida Investments's biggest Q1 2022 reduction was ICU Medical, cutting an estimated $14M.
  • Pura Vida Investments fully exited Natera in Q1 2022, selling an estimated $14.1M.
  • Pura Vida Investments's ten largest holdings make up 37% of its $3.08B portfolio in Q1 2022.
  • Pura Vida Investments opened 89 new positions and closed 96 in Q1 2022.
  • Pura Vida Investments's portfolio value rose 12% quarter-over-quarter to $3.08B.

Based on Pura Vida Investments's 13F filing for Q1 2022, filed 16 May 2022.